The impact of nicotine smoking on spondyloarthritis and rheumatoid arthritis
Submitted: 2 March 2023
Accepted: 18 March 2024
Published: 24 June 2024
Accepted: 18 March 2024
Abstract Views: 3041
PDF: 1197
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- E. Molteni, C. Pirone, F. Ceccarelli, C. Castellani, C. Alessandri, M. Di Franco, V. Riccieri, F.R. Spinelli, R. Priori, R. Scrivo, F. Conti, Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort , Reumatismo: Vol. 76 No. 2 (2024)
- Abdallah Alqethami, Sabri Alsaeedi, Samera Felemban, Abdulelah Qadi, Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review , Reumatismo: Early Access
- A. Marchesoni, F. Cantini, Classification and clinical assessment , Reumatismo: Vol. 64 No. 2 (2012)
- A. Bortoluzzi, M. Padovan, I. Farina, E. Galuppi, F. De Leonardis, M. Govoni, Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre , Reumatismo: Vol. 64 No. 6 (2012)
- M. Manara, D. Bruno, M. Ferrito, S. Perniola, R.F. Caporali, E. Gremese, Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology , Reumatismo: Vol. 76 No. 3 (2024)
- C. Botsios, P. Ostuni, S. Todesco, Incidence and management of infusion reactions to infliximab in 186 italian patient’s with rheumatoid arthritis: the Padua experience , Reumatismo: Vol. 57 No. 1 (2005)
- A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco, Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab , Reumatismo: Vol. 58 No. 2 (2006)
- E. Cárdenas-Cloud, A.J.L. Brambila-Tapia, R.M. Meda-Lara, F.d.J. Pérez-Vázquez, E. Chavarría-Ávila, F.J. Romero-Abundis, M. Vázquez-del-Mercado, Evaluation of a psychoeducational intervention including emotional intelligence to increase treatment adherence in rheumatoid arthritis (A pilot study) , Reumatismo: Vol. 73 No. 3 (2021)
- B. Ristic, C. Bonetto, M. Rossini, E. Fracassi, A. Carletto, S. Tosato, Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis , Reumatismo: Vol. 76 No. 3 (2024)
- L. Riente, The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis , Reumatismo: Vol. 56 No. s1 (2004)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
You may also start an advanced similarity search for this article.